Literature DB >> 15987274

Functional properties of ES cell-derived neurons engrafted into the hippocampus of adult normal and chronically epileptic rats.

Christiane Rüschenschmidt1, Peter G Koch, Oliver Brüstle, Heinz Beck.   

Abstract

PURPOSE: Embryonic stem (ES) cell-based therapy strategies are thought to bear considerable promise in chronic neurologic disorders. Nonetheless, studies addressing the functional properties of ES cell-derived progeny after transplantation into the adult, pathologically modified CNS are scarce.
METHODS: We therefore transplanted ES cell-derived neural precursors expressing enhanced green fluorescent protein only in neuronal progeny bilaterally into the hippocampi of pilocarpine-treated chronically epileptic and sham-control rats. Whole-cell patch-clamp recordings of identified ES cell-derived neurons (ESNs) in hippocampal slices were performed 13 to 34 days after transplantation.
RESULTS: Most ESNs were found in clusters at the transplant site and did not migrate into host tissue. However, they gave rise to a dense network of processes extending over large distances into the host tissue. All ESNs possessed the ability to generate action potentials and expressed voltage-gated Na+ and K+ currents, as well as hyperpolarization-activated currents. Likewise, most ESNs received non-N-methyl-D-aspartate (NMDA) and gamma-aminobutyric acid (GABA)A receptor-mediated synaptic input. Both types of synapses displayed intact short-term plasticity. An unusual feature of the majority of ESNs was the occurrence of spontaneous pacemaking activity at frequencies approximately 3 Hertz. No obvious differences were found between the functional properties of ESNs in sham-control and in pilocarpine-treated rats.
CONCLUSIONS: After transplantation into adult control and epileptic rats, ESNs displayed intrinsic and synaptic properties characteristic of neurons. Even though ESNs remained close to the transplant site, the formation of extensive networks of graft-derived processes may be useful for ES cell-based substance delivery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15987274     DOI: 10.1111/j.1528-1167.2005.01028.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  20 in total

Review 1.  Stem cells as a potential therapy for epilepsy.

Authors:  Steven N Roper; Dennis A Steindler
Journal:  Exp Neurol       Date:  2012-01-13       Impact factor: 5.330

2.  Cortical inhibition modified by embryonic neural precursors grafted into the postnatal brain.

Authors:  Manuel Alvarez-Dolado; Maria Elisa Calcagnotto; Kameel M Karkar; Derek G Southwell; Dorothy M Jones-Davis; Rosanne C Estrada; John L R Rubenstein; Arturo Alvarez-Buylla; Scott C Baraban
Journal:  J Neurosci       Date:  2006-07-12       Impact factor: 6.167

3.  Cell and gene therapies for refractory epilepsy.

Authors:  Detlev Boison
Journal:  Curr Neuropharmacol       Date:  2007       Impact factor: 7.363

Review 4.  Neurotransmitter receptor expression and activity during neuronal differentiation of embryonal carcinoma and stem cells: from basic research towards clinical applications.

Authors:  H Ulrich; P Majumder
Journal:  Cell Prolif       Date:  2006-08       Impact factor: 6.831

5.  Differentiation and functional incorporation of embryonic stem cell-derived GABAergic interneurons in the dentate gyrus of mice with temporal lobe epilepsy.

Authors:  Xu Maisano; Elizabeth Litvina; Stephanie Tagliatela; Gloster B Aaron; Laura B Grabel; Janice R Naegele
Journal:  J Neurosci       Date:  2012-01-04       Impact factor: 6.167

Review 6.  Recent advancements in stem cell and gene therapies for neurological disorders and intractable epilepsy.

Authors:  Janice R Naegele; Xu Maisano; Jia Yang; Sara Royston; Efrain Ribeiro
Journal:  Neuropharmacology       Date:  2010-02-08       Impact factor: 5.250

Review 7.  Adenosine-associated delivery systems.

Authors:  Mehdi Kazemzadeh-Narbat; Nasim Annabi; Ali Tamayol; Rahmi Oklu; Amyl Ghanem; Ali Khademhosseini
Journal:  J Drug Target       Date:  2015       Impact factor: 5.121

Review 8.  Embryonic stem cell-derived neural precursor grafts for treatment of temporal lobe epilepsy.

Authors:  Xu Maisano; Joseph Carpentino; Sandy Becker; Robert Lanza; Gloster Aaron; Laura Grabel; Janice R Naegele
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

Review 9.  Transplantation of GABA-producing cells for seizure control in models of temporal lobe epilepsy.

Authors:  Kerry Thompson
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

Review 10.  Intraventricular and intracerebral delivery of anti-epileptic drugs in the kindling model.

Authors:  Juan A Barcia; José M Gallego
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.